Skip to main content

MYLAN 8008 MYLAN 8008 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint MYLAN 8008 MYLAN 8008 is Purple / White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Mylan Pharmaceuticals Inc.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 8008 MYLAN 8008

Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint
MYLAN 8008 MYLAN 8008
Strength
125 mg
Color
Purple / White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
ammonia, silicon dioxide, copovidone, croscarmellose sodium, dibutyl sebacate, FD&C Blue No. 2, lactose monohydrate, maltodextrin, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, oleic acid, polysorbate 80, ferric oxide red, sodium hydroxide, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triacetin, triethyl citrate, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-8008 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0765 (Discontinued) UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.